サマリー

がん免疫療法の世界市場 2023-2027
がん免疫療法市場は、2022-2027年に385億7000万米ドルで成長し、予測期間中のCAGRは7.42%で加速すると予測される。当レポートでは、がん免疫療法市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、がんの高い有病率、がん免疫療法に関する消費者の意識の高まり、モノクローナル抗体の強力な研究開発パイプラインによって牽引されている。
Technavioのがん免疫療法市場は以下のように区分される：
タイプ別
- モノクローナル抗体
- チェックポイント阻害薬および免疫調節薬
- がんワクチン
用途別
- 肺がん
- 乳がん
- 大腸がん
- その他
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、がん免疫療法市場成長のための様々な戦略の採用が、今後数年間のがん免疫療法市場成長を促進する主要な理由の1つであるとしている。また、がん治療のための新たな治療法の出現や、先進的な診断方法の利用可能性は、市場の大きな需要につながる。
本レポートでは、がん免疫療法市場について以下の領域をカバーしている：
- がん免疫療法市場のサイジング
- がん免疫療法市場の予測
- がん免疫療法市場の産業分析
強固なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、本レポートでは、いくつかの主要ながん免疫療法市場ベンダーの詳細な分析を提供しています：Amgen社、Amneal Pharmaceuticals社、AstraZeneca Plc社、Bayer AG社、Bristol Myers Squibb社、Dendreon Pharmaceuticals LLC社、Eli Lilly社、F. Hoffmann La Roche社、Fresenius SE and Co.KGaA、ギリアド・サイエンシズInc.、グラクソ・スミスクラインPlc、イムノコア・ホールディングスPlc、イノビオ・ファーマシューティカルズInc.、ジョンソン・アンド・ジョンソン、メルクKGaA、ノバルティスAG、ファイザーInc.、サノフィ、セーゲンInc.、武田薬品工業Inc.武田薬品工業株式会社）である。また、がん免疫療法市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものである。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/cancer-immunotherapy-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global cancer immunotherapy market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global cancer immunotherapy market 2017 - 2021 ($ billion)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Monoclonal antibodies - Market size and forecast 2022-2027
o Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2022-2027 (%)
o 6.4 Check point inhibitors and immunomodulators - Market size and forecast 2022-2027
o Exhibit 38: Chart on Check point inhibitors and immunomodulators - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Check point inhibitors and immunomodulators - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Check point inhibitors and immunomodulators - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Check point inhibitors and immunomodulators - Year-over-year growth 2022-2027 (%)
o 6.5 Cancer vaccines - Market size and forecast 2022-2027
o Exhibit 42: Chart on Cancer vaccines - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Cancer vaccines - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Cancer vaccines - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Cancer vaccines - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Type
o Exhibit 46: Market opportunity by Type ($ billion)
o Exhibit 47: Data Table on Market opportunity by Type ($ billion)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 48: Chart on Application - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 50: Chart on Comparison by Application
o Exhibit 51: Data Table on Comparison by Application
o 7.3 Lung cancer - Market size and forecast 2022-2027
o Exhibit 52: Chart on Lung cancer - Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Data Table on Lung cancer - Market size and forecast 2022-2027 ($ billion)
o Exhibit 54: Chart on Lung cancer - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Lung cancer - Year-over-year growth 2022-2027 (%)
o 7.4 Breast cancer - Market size and forecast 2022-2027
o Exhibit 56: Chart on Breast cancer - Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on Breast cancer - Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on Breast cancer - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Breast cancer - Year-over-year growth 2022-2027 (%)
o 7.5 Colorectal cancer - Market size and forecast 2022-2027
o Exhibit 60: Chart on Colorectal cancer - Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Colorectal cancer - Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Colorectal cancer - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Colorectal cancer - Year-over-year growth 2022-2027 (%)
o 7.6 Others - Market size and forecast 2022-2027
o Exhibit 64: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Application
o Exhibit 68: Market opportunity by Application ($ billion)
o Exhibit 69: Data Table on Market opportunity by Application ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 France - Market size and forecast 2022-2027
o Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 119: Amgen Inc. - Overview
o Exhibit 120: Amgen Inc. - Product / Service
o Exhibit 121: Amgen Inc. - Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 122: AstraZeneca Plc - Overview
o Exhibit 123: AstraZeneca Plc - Product / Service
o Exhibit 124: AstraZeneca Plc - Key news
o Exhibit 125: AstraZeneca Plc - Key offerings
o 12.5 Bayer AG
o Exhibit 126: Bayer AG - Overview
o Exhibit 127: Bayer AG - Business segments
o Exhibit 128: Bayer AG - Key news
o Exhibit 129: Bayer AG - Key offerings
o Exhibit 130: Bayer AG - Segment focus
o 12.6 Bristol Myers Squibb Co.
o Exhibit 131: Bristol Myers Squibb Co. - Overview
o Exhibit 132: Bristol Myers Squibb Co. - Product / Service
o Exhibit 133: Bristol Myers Squibb Co. - Key news
o Exhibit 134: Bristol Myers Squibb Co. - Key offerings
o 12.7 Eli Lilly and Co.
o Exhibit 135: Eli Lilly and Co. - Overview
o Exhibit 136: Eli Lilly and Co. - Product / Service
o Exhibit 137: Eli Lilly and Co. - Key news
o Exhibit 138: Eli Lilly and Co. - Key offerings
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 139: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 140: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 141: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 142: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 143: F. Hoffmann La Roche Ltd. - Segment focus
o 12.9 Gilead Sciences Inc.
o Exhibit 144: Gilead Sciences Inc. - Overview
o Exhibit 145: Gilead Sciences Inc. - Product / Service
o Exhibit 146: Gilead Sciences Inc. - Key news
o Exhibit 147: Gilead Sciences Inc. - Key offerings
o 12.10 GlaxoSmithKline Plc
o Exhibit 148: GlaxoSmithKline Plc - Overview
o Exhibit 149: GlaxoSmithKline Plc - Business segments
o Exhibit 150: GlaxoSmithKline Plc - Key news
o Exhibit 151: GlaxoSmithKline Plc - Key offerings
o Exhibit 152: GlaxoSmithKline Plc - Segment focus
o 12.11 Immunocore Holdings Plc
o Exhibit 153: Immunocore Holdings Plc - Overview
o Exhibit 154: Immunocore Holdings Plc - Product / Service
o Exhibit 155: Immunocore Holdings Plc - Key offerings
o 12.12 Johnson and Johnson
o Exhibit 156: Johnson and Johnson - Overview
o Exhibit 157: Johnson and Johnson - Business segments
o Exhibit 158: Johnson and Johnson - Key news
o Exhibit 159: Johnson and Johnson - Key offerings
o Exhibit 160: Johnson and Johnson - Segment focus
o 12.13 Merck KGaA
o Exhibit 161: Merck KGaA - Overview
o Exhibit 162: Merck KGaA - Business segments
o Exhibit 163: Merck KGaA - Key news
o Exhibit 164: Merck KGaA - Key offerings
o Exhibit 165: Merck KGaA - Segment focus
o 12.14 Novartis AG
o Exhibit 166: Novartis AG - Overview
o Exhibit 167: Novartis AG - Business segments
o Exhibit 168: Novartis AG - Key offerings
o Exhibit 169: Novartis AG - Segment focus
o 12.15 Pfizer Inc.
o Exhibit 170: Pfizer Inc. - Overview
o Exhibit 171: Pfizer Inc. - Product / Service
o Exhibit 172: Pfizer Inc. - Key news
o Exhibit 173: Pfizer Inc. - Key offerings
o 12.16 Sanofi
o Exhibit 174: Sanofi - Overview
o Exhibit 175: Sanofi - Business segments
o Exhibit 176: Sanofi - Key news
o Exhibit 177: Sanofi - Key offerings
o Exhibit 178: Sanofi - Segment focus
o 12.17 Takeda Pharmaceutical Co. Ltd.
o Exhibit 179: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 180: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 181: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 182: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 183: Inclusions checklist
o Exhibit 184: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 185: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 186: Research methodology
o Exhibit 187: Validation techniques employed for market sizing
o Exhibit 188: Information sources
o 13.5 List of abbreviations
o Exhibit 189: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global cancer immunotherapy market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Monoclonal antibodies - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Monoclonal antibodies - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Monoclonal antibodies - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Monoclonal antibodies - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Check point inhibitors and immunomodulators - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Check point inhibitors and immunomodulators - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Check point inhibitors and immunomodulators - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Check point inhibitors and immunomodulators - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Cancer vaccines - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Cancer vaccines - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Cancer vaccines - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Cancer vaccines - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Type ($ billion)
Exhibits47: Data Table on Market opportunity by Type ($ billion)
Exhibits48: Chart on Application - Market share 2022-2027 (%)
Exhibits49: Data Table on Application - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Application
Exhibits51: Data Table on Comparison by Application
Exhibits52: Chart on Lung cancer - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on Lung cancer - Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on Lung cancer - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Lung cancer - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Breast cancer - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Breast cancer - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Breast cancer - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Breast cancer - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Colorectal cancer - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Colorectal cancer - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Colorectal cancer - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Colorectal cancer - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Application ($ billion)
Exhibits69: Data Table on Market opportunity by Application ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ billion)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Amgen Inc. - Overview
Exhibits120: Amgen Inc. - Product / Service
Exhibits121: Amgen Inc. - Key offerings
Exhibits122: AstraZeneca Plc - Overview
Exhibits123: AstraZeneca Plc - Product / Service
Exhibits124: AstraZeneca Plc - Key news
Exhibits125: AstraZeneca Plc - Key offerings
Exhibits126: Bayer AG - Overview
Exhibits127: Bayer AG - Business segments
Exhibits128: Bayer AG - Key news
Exhibits129: Bayer AG - Key offerings
Exhibits130: Bayer AG - Segment focus
Exhibits131: Bristol Myers Squibb Co. - Overview
Exhibits132: Bristol Myers Squibb Co. - Product / Service
Exhibits133: Bristol Myers Squibb Co. - Key news
Exhibits134: Bristol Myers Squibb Co. - Key offerings
Exhibits135: Eli Lilly and Co. - Overview
Exhibits136: Eli Lilly and Co. - Product / Service
Exhibits137: Eli Lilly and Co. - Key news
Exhibits138: Eli Lilly and Co. - Key offerings
Exhibits139: F. Hoffmann La Roche Ltd. - Overview
Exhibits140: F. Hoffmann La Roche Ltd. - Business segments
Exhibits141: F. Hoffmann La Roche Ltd. - Key news
Exhibits142: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits143: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits144: Gilead Sciences Inc. - Overview
Exhibits145: Gilead Sciences Inc. - Product / Service
Exhibits146: Gilead Sciences Inc. - Key news
Exhibits147: Gilead Sciences Inc. - Key offerings
Exhibits148: GlaxoSmithKline Plc - Overview
Exhibits149: GlaxoSmithKline Plc - Business segments
Exhibits150: GlaxoSmithKline Plc - Key news
Exhibits151: GlaxoSmithKline Plc - Key offerings
Exhibits152: GlaxoSmithKline Plc - Segment focus
Exhibits153: Immunocore Holdings Plc - Overview
Exhibits154: Immunocore Holdings Plc - Product / Service
Exhibits155: Immunocore Holdings Plc - Key offerings
Exhibits156: Johnson and Johnson - Overview
Exhibits157: Johnson and Johnson - Business segments
Exhibits158: Johnson and Johnson - Key news
Exhibits159: Johnson and Johnson - Key offerings
Exhibits160: Johnson and Johnson - Segment focus
Exhibits161: Merck KGaA - Overview
Exhibits162: Merck KGaA - Business segments
Exhibits163: Merck KGaA - Key news
Exhibits164: Merck KGaA - Key offerings
Exhibits165: Merck KGaA - Segment focus
Exhibits166: Novartis AG - Overview
Exhibits167: Novartis AG - Business segments
Exhibits168: Novartis AG - Key offerings
Exhibits169: Novartis AG - Segment focus
Exhibits170: Pfizer Inc. - Overview
Exhibits171: Pfizer Inc. - Product / Service
Exhibits172: Pfizer Inc. - Key news
Exhibits173: Pfizer Inc. - Key offerings
Exhibits174: Sanofi - Overview
Exhibits175: Sanofi - Business segments
Exhibits176: Sanofi - Key news
Exhibits177: Sanofi - Key offerings
Exhibits178: Sanofi - Segment focus
Exhibits179: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits180: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits181: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits182: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits183: Inclusions checklist
Exhibits184: Exclusions checklist
Exhibits185: Currency conversion rates for US$
Exhibits186: Research methodology
Exhibits187: Validation techniques employed for market sizing
Exhibits188: Information sources
Exhibits189: List of abbreviations